Antibiotic resistant hospital bacteria

submitted by: COMED2010
MOSAR aims to significantly advance our knowledge regarding the control of antimicrobial resistance of bacteria responsible for major and emerging nosocomial diseases in hospitals, which are now spreading into communities. MOSAR will examine the factors determining the dynamics of spread of AMRB within healthcare facilities and the relative efficacity and medicoeconomic impact of control strategies. The resulting new knowledge will be disseminated to caregivers and health policy makers and...

Evaluation of toxicity and mutagenicity of trichosetin, an anti-MRSA antibiotic

submitted by: UP Los Baños
A report on the UPLB Basic Research Program-funded study aimed to evaluate the potential risk of trichosetin as a therapeutic agent for methicillin- resistant Staphylococcus aureus (MRSA) infection. Speficifically the study determined the (1) oral LD50 of trichosetin in mice, (2) the effect of trichosetin on vital organs, and the (3) mutagenicity of trichosetin. Dr. Eufrocinio C. Marfori National Institute of Molecular Biology and Biotechnology University of the Philippines Los Baños...